Skin testing for IgE-mediated drug allergy

Area of Science:

• Clinical Immunology
• Pharmacology
• Dermatology

Background:

• Adverse drug reactions (ADRs) are frequently diagnosed using patient history and clinical presentation.
• Drug hypersensitivity reactions (DHRs) require specific diagnostic approaches to identify causative agents and mechanisms.
• Type I, IgE-mediated allergic drug reactions necessitate specialized diagnostic tools.

Purpose of the Study:

• To evaluate the utility of skin testing in diagnosing drug hypersensitivity reactions.
• To compare the efficacy of skin tests with laboratory assays for IgE antibodies.
• To highlight the safety considerations for performing intradermal skin tests.

Main Methods:

• Skin prick testing and intradermal testing were employed.
• Diagnostic accuracy was assessed against clinical presentation and, where available, laboratory assays for IgE antibodies.
• Safety data regarding adverse events from intradermal testing were considered.

Main Results:

• Skin tests, including prick and intradermal methods, offer rapid and supportive evidence for diagnosing or excluding IgE-mediated drug allergies.
• These tests can be more sensitive than available laboratory assays for detecting drug-specific IgE antibodies.
• Intradermal skin tests carry a risk of adverse events, necessitating expert administration.

Conclusions:

• Skin testing is a crucial diagnostic modality for drug hypersensitivity, particularly for IgE-mediated reactions.
• The diagnostic performance of skin tests often surpasses that of current laboratory IgE assays.
• Safe execution of intradermal skin testing requires experienced personnel and an appropriate clinical setting.